Conatus Pharmaceuticals Inc
Conatus Pharmaceuticals Inc (CNAT) is a publicly traded company in the Unknown sector. Across all available filings, 20 corporate insiders have executed 91 transactions totaling $17.2M, demonstrating a bullish sentiment with $17.2M in net insider flow. The most recent transaction on Nov 14, 2018 involved a transaction of 1,861 shares valued at $5.9K.
CNAT Insider Activity Summary
Who Is Buying CNAT Stock?
No significant insider buying has been recorded for CNAT in the recent period.
Who Is Selling CNAT Stock?
No significant insider selling has been recorded for CNAT in the recent period.
Is Conatus Pharmaceuticals Inc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CNAT is bullish with an Insider Alignment Score of 100/100 and a net flow of $17.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CNAT Frequently Asked Questions
Understanding CNAT Insider Activity
Insider trading at Conatus Pharmaceuticals Inc (CNAT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 20 insiders are actively trading CNAT stock, having executed 91 transactions in the past 90 days. The most active insider is Venture Partners Llp Advent (Executive), who has made 5 transactions totaling $2.3M.
Related Tools
Track Conatus Pharmaceuticals Inc Insider Activity
Get notified when executives and directors at CNAT file new Form 4 transactions